TABLE 3.
Study | Year | Sample size (pts) | Technique | Sensitivity, % |
---|---|---|---|---|
Pugliese et al21 | 1995 | 94 | Brush + biopsy | 61 |
Ponchon et al19 | 1995 | 233 | Brush + biopsy | 63 |
Jailwala et al17 | 2000 | 133 | Brush + biopsy | 48 |
Rösch et al22 | 2004 | 50 | Brush + biopsy | 54 |
Kitajima et al18,* | 2007 | 60 | Brush + biopsy | 74 |
Weber et al24 | 2008 | 58 | Brush + biopsy | 60 |
High-grade dysplasia was considered malignant to calculate the sensitivity.